You are here: Industry Insights > CDMO

News List

Sterling Pharma Aquires CiVentiChem in the US contractpharma
April 03, 2019
Enhance chemistry development capabilities to support pre-clinical and early phase clinical supply
Pii to Manufacture Busulfan Injection Drug Product contractpharma
March 19, 2019
Busulfan Injection is the 4th injectable product approved by the FDA for Pii and its partners.
Fujifilm grabs Biogen biologics plant in Europe to bolster its CDMO business fiercepharma
March 13, 2019
Biogen will open brand-new biologics facilities in Switzerland and has decided it no longer needs its older operations in Denmark.
Mallinckrodt invests $100M in its BioVectra CDMO en-cphi.cn
March 08, 2019
The Canadian operations plant where Mallinckrodt makes the API for its controversial—and pricey—H.P. Acthar Gel is expanding and getting some Canadian tax dollars to help with the expense.
Former AstraZeneca UK plant back up for sale, putting 270 jobs at risk fiercepharma
February 20, 2019
A CDMO that has made a habit of snapping up Big Pharma’s discarded manufacturing plants has put a former AstraZeneca plant into bankruptcy.
Novartis Makes Offer for French CDMO contractpharma
December 27, 2018
Novartis has made an offer to acquire CellforCurefrom LFB. CellforCure, a French company, is one of the first and largest contract development and manufacturing organizations (CDMO) producing cell and gene therapies in Europe.
Novartis offers to buy Kymriah manufacturer pharmaphorum
December 24, 2018
Following its success in the burgeoning area of CAR-T therapies, Novartis is looking to strengthen its cell and gene manufacturing capabilities by offering to acquire CDMO CellforCure, manufacturers of its CAR-T drug Kymriah.
Novartis makes offer to acquire French CDMO CellforCure pharmaceutical-technology
December 24, 2018
Novartis has made an offer to acquire CellforCure, a France-based contract development and manufacturing organisation (CDMO) producing cell and gene therapies in Europe, from LFB for an undisclosed amount.....
140 jobs in jeopardy as Recipharm weighs the fate of money-losing plant fiercepharma
December 20, 2018
A Recipharm plant in the U.K. has been on the edge financially for some time, having been unprofitable for three years. Now, the Swedish-based CDMO says the cost of fixing issues raised by U.K. authorities may be the breaking point.
Rentschler Biopharma to Purchase U.S. Manufacturing Site from Shire americanpharmaceuticalreview
December 18, 2018
Rentschler Biopharma announced the company has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA......

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page